ADCY1 and cancer: Cationic amphiphilic drug (CAD) repurposing is an emerging therapeutic approach for cancer therapy, and recently a study demonstrated that the CAD/P2XR4/ADCY1/Ca2+ signalling pathway is critical for CAD-induced lysosome-dependent cell death26, although the cellular mechanisms underlying this phenomenon are a matter of speculation.